Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Thierry Zénone, Britta Maurer et al.|Annals of the Rheumatic Diseases|2014Cited by 432